Evidence map›Paper›PMID 23538482›Full record

ReviewCirculation journal : official journal of the Japanese Circulation Society2013

Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore.

John W Elrod, Jeffery D Molkentin

Open access · diamondAbstract readReview
In one paragraph

Review in Circulation journal : official journal of the Japanese Circulation Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 1 synthesis or guideline pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Mitochondrial CaJournal of cellular physiology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Genetic Markers of Postmortem Brain Iron.Journal of neurochemistry · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

John W ElrodCenter for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA. elrod@temple.edu
Jeffery D Molkentin
Cincinnati Children's Hospital Medical Center · USTemple University · US

Funding

DEFINING THE ROLE OF NECROTIC CELL DEATH IN THE PROGRESSION OF HEART FAILUREF32HL092737 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI ELROD, JOHN WILLIAM · 2008 to 2009
$97k
Howard Hughes Medical InstituteNHLBI NIH HHS F32 HL092737
6 · The paper itself

Abstract

This review focuses on the role of cyclophilin D (CypD) as a prominent mediator of the mitochondrial permeability transition pore (MPTP) and subsequent effects on cardiovascular physiology and pathology. Although a great number of reviews have been written on the MPTP and its effects on cell death, we focus on the biology surrounding CypD itself and the non-cell death physiologic functions of the MPTP. A greater understanding of the physiologic functions of the MPTP and its regulation by CypD will likely suggest novel therapeutic approaches for cardiovascular disease, both dependent and independent of programmed necrotic cell death mechanisms.

Indexed as

AnimalsApoptosisCyclophilinsEnergy MetabolismHumansMitochondria, HeartMitochondrial MembranesMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMyocardial Reperfusion InjuryMyocytes, CardiacNecrosisPeptidyl-Prolyl Isomerase FPhylogenyProtein Processing, Post-TranslationalCyclophilinsMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PorePeptidyl-Prolyl Isomerase F

Identifiers

PMID23538482
PMCPMC6397958
OpenAlexW1966329382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.